PESSAC, France--(BUSINESS WIRE)--Hyprevention has raised new financing to support the V-STRUT© Vertebral Implant product. The financing will be used to execute the commercialization plans for the US spinal fracture market....
PETOSKEY, Mich.--(BUSINESS WIRE)--BioStar Capital, a value-add investment firm focused on transformational medical device technologies that serve unmet patient needs in cardiovascular and orthopedic medicine, today announced that Mark Toland, former...
Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L antibody, in development for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases Senior management team with extensive drug development and...
Company launches http://www.biorez.com featuring its new BioBrace™ technology. NEW HAVEN, CONN. (PRWEB) SEPTEMBER 09, 2020 Biorez, Inc., a medical device company advancing tendon and ligament repair, announced today that it has raised $3.5 million...
The acquisition of the FIBRINET system adds new novel technology to Royal Biologics' growing portfolio of Autologous Live Cell solutions HACKENSACK, N.J., September 1, 2020 (Newswire.com) - HACKENSACK, N.J., September 1, 2020...
SAN DIEGO, Aug. 31, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today...
Salt Lake City, UT – August 25, 2020 – DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative...